The Deadpool
What happened to companies that raised private capital, from public records. Shutdowns and acquisitions are listed only with the evidence behind them.
Exits, not failures. Each acquisition is backed by a public record, such as an SEC change-in-control filing or the acquirer's filing announcing the completed deal.
477 companies
SpringWorks Therapeutics
Other Health CareStamford, CT
Acquired · Jul 2025
$125.0M raised (Form D) Last Form D Apr 2019
- Acquisition record· SEC EDGAR· Jul 1, 2025SEC 8-K filed by SpringWorks Therapeutics, Inc.: the filer completed its acquisition of SpringWorks TherapeuticsSource
- Acquisition record· SEC EDGAR· Jul 1, 2025SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
Aerie Pharmaceuticals
PharmaceuticalsBedminster, NJ
Acquired · Nov 2022
$125.0M raised (Form D) Last Form D Sep 2014
- Acquisition record· SEC EDGAR· Nov 21, 2022SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
- Acquisition record· SEC EDGAR· Oct 7, 2022SEC DEFM14A filed by AERIE PHARMACEUTICALS INC: Aerie Pharmaceuticals became a wholly owned subsidiarySource
- Company website· Wikidata· Oct 18, 2026Website aeriepharma.com: listed by Wikidata (matched by SEC CIK)Source
Metacrine
PharmaceuticalsSan Diego, CA
Acquired by Equillium · Sep 2022
$124.8M raised (Form D) Last Form D Jun 2018
- Website dead· Domain check· Oct 18, 2026Website metacrine.com is a parked / for-sale pageSource
- Acquisition record· SEC EDGAR· Sep 26, 2022SEC EX-99.2 filed by Equillium, Inc.: Metacrine became a wholly owned subsidiary of EquilliumSource
- Company website· Internet Archive· Oct 18, 2026Website metacrine.com: archived copy of the site from around the company's last raise shows its name and HQ locationSource
- Acquisition record· SEC EDGAR· Mar 24, 2023SEC 425 merger filing, followed by Form 15-12G deregistrationSource
Berkeley Lights
BiotechnologyEmeryville, CA
Acquired · Oct 2023
$124.7M raised (Form D) Last Form D Oct 2018
- Acquisition record· SEC EDGAR· Oct 2, 2023SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
Axonics Modulation Technologies
Other TechnologyIrvine, CA
Acquired · Nov 2024
$124.4M raised (Form D) Last Form D Apr 2018
- Acquisition record· SEC EDGAR· Nov 15, 2024SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
New Relic
Other TechnologySan Francisco, CA
Acquired · Nov 2023
$123.2M raised (Form D) Last Form D Nov 2015
- Acquisition record· SEC EDGAR· Nov 8, 2023SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
- Company website· Wikidata· Oct 18, 2026Website newrelic.com: listed by Wikidata (matched by SEC CIK)Source
Kronos Bio
BiotechnologySan Mateo, CA
Acquired · Jun 2025
$123.0M raised (Form D) Last Form D Jul 2019
- Acquisition record· SEC EDGAR· Jun 20, 2025SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
Scipher Medicine
BiotechnologyWaltham, MA
Acquired by Chemomab Parent · Sep 2026
$123.0M raised (Form D) Last Form D Jul 2024
- Acquisition record· SEC EDGAR· Sep 25, 2026SEC S-4 filed by Snowdrift Parent Corp: Scipher Medicine became a wholly owned subsidiary of Chemomab ParentSource
Maple Parent
RetailingBurlington, MA
Acquired by DPSG · May 2018
$122.9M raised (Form D) Last Form D Oct 2017
- Acquisition record· SEC EDGAR· May 29, 2018SEC DEFM14A filed by Dr Pepper Snapple Group, Inc.: Maple Parent became a wholly owned subsidiary of DPSGSource
Turnstone Biologics
BiotechnologyNew York, NY
Acquired · Aug 2025
$122.1M raised (Form D) Last Form D Jul 2021
- Acquisition record· SEC EDGAR· Aug 11, 2025SEC SC 14D9/A filed by Turnstone Biologics Corp.: the filer completed its acquisition of Turnstone BiologicsSource
- Acquisition record· SEC EDGAR· Aug 11, 2025SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
OnKure
PharmaceuticalsBoulder, CO
Acquired by Reneo · Jun 2024
$122.1M raised (Form D) Last Form D Apr 2023
- Acquisition record· SEC EDGAR· Jun 21, 2024SEC S-4 filed by Reneo Pharmaceuticals, Inc.: OnKure became a wholly owned subsidiary of ReneoSource
Synlogic
BiotechnologyCambridge, MA
Acquired by Mirna · Jun 2017
$121.8M raised (Form D) Last Form D Jun 2019
- Acquisition record· SEC EDGAR· Jun 21, 2017SEC S-4 filed by Mirna Therapeutics, Inc.: Synlogic became a wholly owned subsidiary of MirnaSource
Precision Castparts
ManufacturingLake Oswego, OR
Acquired · Feb 2016
$121.3M raised (Form D) Last Form D Jan 2026
- Acquisition record· SEC EDGAR· Feb 4, 2016SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12B deregistrationSource
- Company website· Wikidata· Oct 18, 2026Website precast.com: listed by Wikidata (matched by SEC CIK)Source
Advisory Board
Business ServicesWashington DC, DC
Acquired · Nov 2017
$121.2M raised (Form D) Last Form D Jan 2015
- Acquisition record· SEC EDGAR· Nov 17, 2017SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
Linkedin
Other TechnologyMountain View, CA
Acquired · Dec 2016
$119.6M raised (Form D) Last Form D Mar 2014
- Acquisition record· SEC EDGAR· Dec 8, 2016SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12B deregistrationSource
Smartsheet
Other TechnologyBellevue, WA
Acquired · Jan 2025
$118.1M raised (Form D) Last Form D Sep 2020
- Acquisition record· SEC EDGAR· Jan 22, 2025SEC 8-K (Item 5.01, change in control of registrant), followed by Form 25-NSE deregistrationSource
- Acquisition record· SEC EDGAR· Nov 4, 2024SEC DEFM14A filed by SMARTSHEET INC: Smartsheet became a wholly owned subsidiarySource
- Company website· Company website· Oct 18, 2026Website smartsheet.com: site shows the company name and its HQ locationSource
Theseus Pharmaceuticals
PharmaceuticalsCambridge, MA
Acquired · Feb 2024
$117.2M raised (Form D) Last Form D Feb 2021
- Acquisition record· SEC EDGAR· Feb 14, 2024SEC SC 14D9/A filed by Theseus Pharmaceuticals, Inc.: the filer completed its acquisition of Theseus PharmaceuticalsSource
- Acquisition record· SEC EDGAR· Feb 26, 2024SEC SC 14D9 merger filing, followed by Form 15-12G deregistrationSource
Corindus Vascular Robotics
Other Health CareWaltham, MA
Acquired · Oct 2019
$117.1M raised (Form D) Last Form D Mar 2019
- Acquisition record· SEC EDGAR· Oct 29, 2019SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12B deregistrationSource
Inozyme Pharma
PharmaceuticalsBoston, MA
Acquired · Jul 2025
$116.3M raised (Form D) Last Form D Jun 2020
- Acquisition record· SEC EDGAR· Jul 1, 2025SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
Talaris Therapeutics
BiotechnologyLouisville, KY
Acquired · Oct 2025
$115.0M raised (Form D) Last Form D Oct 2020
- Acquisition record· SEC EDGAR· Oct 28, 2025SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
Zuora
Other TechnologyFoster City, CA
Acquired · Feb 2025
$115.0M raised (Form D) Last Form D Mar 2015
- Acquisition record· SEC EDGAR· Feb 14, 2025SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
- Company website· Wikidata· Oct 18, 2026Website zuora.com: listed by Wikidata (matched by SEC CIK)Source
CuriosityStream
OtherSilver Spring, MD
Acquired by Software Acquisition Group · Sep 2020
$114.7M raised (Form D) Last Form D Dec 2018
- Acquisition record· SEC EDGAR· Sep 22, 2020SEC DEFM14A filed by Software Acquisition Group Inc.: CuriosityStream became a wholly owned subsidiary of Software Acquisition GroupSource
Oyster Point Pharma
PharmaceuticalsPrinceton, NJ
Acquired · Jan 2023
$113.6M raised (Form D) Last Form D Feb 2019
- Acquisition record· SEC EDGAR· Jan 3, 2023SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-12G deregistrationSource
Sherlock Biosciences
Other Health CareBrighton, MA
Acquired by ORASURE TECHNOLOGIES INC · May 2025
$112.8M raised (Form D) Last Form D Mar 2022
- Acquisition record· SEC EDGAR· May 9, 2025SEC EX-99.1 filed by ORASURE TECHNOLOGIES INC: ORASURE TECHNOLOGIES INC completed its acquisition of Sherlock BiosciencesSource
Sources: SEC Form D and EDGAR filings, Wikidata, the Internet Archive and companies' own websites. Amounts are totals sold as reported on Form D, in USD. If an entry about your company is wrong, use "Request a correction or removal" on it.